Basilea Pharmaceutica Ltd
Climate Impact & Sustainability Data (2023)
Reporting Period: 2023
Environmental Metrics
ESG Focus Areas
- Product quality and safety
- Antimicrobial resistance
- Animal handling
- Compliance (legal and ethical)
- Drug pricing and reimbursement
- Intellectual property protection
- Human capital development
- Diversity, equality and inclusion
- Economic performance
Climate Goals & Targets
Environmental Challenges
- Antimicrobial resistance (AMR) is a global health threat, compromising the effectiveness of current treatments.
Mitigation Strategies
- Development of strategies to incentivize R&D for novel anti-infectives.
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: GRI (2021)